If youre thinking Ill take a GLP-1 so I dont get dementia, discuss with your doctor: current use for brain prevention is off-label, experimental, and still under investigation
Cardiovascular outcome studies Although multiple clinical trials evaluating cardiovascular events associated with GLP-1 RA use as the primary outcome are currently ongoing (Table 1), abundant non-primary outcome data are available from many clinical trials on the efficacy of GLP-1 RAs marketed earlier, such as exenatide (DURATION studies) and liraglutide (LEAD studies)
It commonly supports patients with: How the Program Works Dr
It works as both a GLP-1 agonist and a GIP receptor agonist, which helps explain why patients lose more weight compared to many older medications
As Yuval Ramot from the Department of Dermatology at Hadassah Medical Center notes: "Almost all local reactions to subcutaneously administered biological agents can be prevented by changing the injection techniques, patient education, and training." While most redness and warmth from injections resolve within 24 to 48 hours, mistakes in technique can prolong these symptoms
Current clinical guidance reminds us that phenotypic presentations of type 2 diabetes are highly variable but that there are common unmet needs and conformities in therapeutic strategy [2,3,4]